Skip to main content

Showing results for Research Findings

Painful Bias

How does bias in pain management impact a patient’s well-being? How can we eliminate it among medical providers? A new study aims to find solutions.

Bobby King  |  May 26, 2021

Healer, Mentor, Researcher, Leader

Wade Clapp helped discover treatments for a rare genetic disorder and paved a path for future physician-scientists.

Matthew Harris  |  Nov 10, 2020

The Search

Over the last 25 years, hundreds of clinical trials for drugs treating Alzheimer’s disease have failed. As the field takes stock, a team at IU School of Medicine hunts for new targets—and hope for patients.

Matthew Harris  |  Nov 10, 2020

MEDTalk 2020: Harnessing genomics, halting ALS, and finding freedom

Three presenters share how research and medical education at IU School of Medicine can shape a world of better health. 

After Early Success, IU Poised to Grow CAR T Program

The Tilley family’s experience shows the life-saving potential of immunotherapy—and underscores why Indiana University School of Medicine wants to scale up its staff to treat more patients.

Matthew Harris  |  Feb 19, 2020

Helping Babies to a Healthy Start

With a dozen community health workers, the WeCare program assists at-risk mothers in Indianapolis navigate pregnancy—and hopes the model could lower Indiana’s infant mortality rate.

Selling Out to Stop ALS

Sherry and Mike Sonneborn gave up their retirement home to fund research to halt the neurodegenerative disease.

Budding Hope to Save Sight

COMBING THE SCIENTIFIC literature, Tim Corson, PhD, searched for a new way to treat macular degeneration, the deterioration of part of the retina. It led to him to an unlikely place. A delicate orchid. Or more accurately, a medicinal compound the orchid produces. Patients diagnosed with wet age-related macular degeneration spend their golden years in a gauzy haze. Inside their eye, abnormal blood vessels sprout underneath tissue in the center of the retina. These vessels leak fluid, creating scar tissue. […]

Coupled in the Fight Against Cancer

XIONGBIN LU, PhD, spends his days engrossed in research into the factors that lead normal breast tissue cells to turn into Triple Negative Breast Cancer—and engineering therapies to stop it. Across the hall from Lu’s lab, Xinna Zhang, PhD, dives deeply into her the study of the biology of HER2-positive breast cancer, and what makes cells resistant to drug therapies. But Lu and Zhang share more than their proximity to one another in the Vera Bradley Foundation Breast Cancer Research […]

Truly Healed

Because of a revolutionary therapy developed by Dr. Larry Einhorn and his colleagues at IU School of Medicine, James Mikesh is part of a legion of survivors of a disease that once killed 95 percent of patients. Now, 95 percent of patients are cured.